Safety and Efficacy Study of PRI-724 in Subjects With Advanced Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01302405
Recruitment Status : Terminated (closing due to low enrollment, no safety issues)
First Posted : February 24, 2011
Last Update Posted : August 17, 2017
inVentiv Health Clinical
Information provided by (Responsible Party):
Prism Pharma Co., Ltd.

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : January 2015
  Actual Study Completion Date : June 2015